Sponsor:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- HHS Small Business Innovation Research (SBIR) Program Contract Solicitation (PHS 2019-1) Now Available
Office of the Director, NIH - Updated Notice of NIH's Interest in Diversity
Office of the Director, NIH - NIH Implementation of the Burden-Reducing Provisions of the 2018 Common Rule
Office of the Director, NIH - Delayed Enforcement and Short-Term Flexibilities for Some Requirements Affecting Prospective Basic Science Studies Involving Human Participants
Office of the Director, NIH - Notice of Information: Initiative for Collaborative Research Between Investigators in the USA and in Norway
National Institute of Allergy and Infectious Diseases - Notice of Intent to Publish a Funding Opportunity Announcement for NCCIH Supplements to NCATS CTSA Programs for Scholars Pursuing Complementary Health Research Career Development (Admin Supp; Clinical Trial Optional)
National Center for Complementary and Integrative Health - Notice of Change of Requirements for PAR-18-218, "Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01 Clinical Trial Optional)"
National Institute on Drug Abuse - Notice of Change of Requirements for PAR-18-219, "Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)"
National Institute on Drug Abuse - Notice of Intent to Publish a Funding Opportunity Announcement for Data Coordinating Center for the HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (UM1)
National Institute on Drug Abuse - Notice of Intent to Publish a Funding Opportunity Announcement for Research Site for the HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (UM1)
National Institute on Drug Abuse - Notice of Correction to Letter of Reference Receipt Date in RFA-DA-18-019 NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1, Clinical Trial Optional)
National Institute on Drug Abuse - Notice of Early Application Receipt Date for PAR-18-854, Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Behavioral and Social Science Research
Office of Disease Prevention - Notice of Clarification for PAR-18-844-Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
National Human Genome Research Institute - Notice of Clarification to PAR-18-843: Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
National Human Genome Research Institute - Notice of Information: Change in Letter of Intent Due Dates for PAR-18-747 "Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional)"
National Institute on Minority Health and Health Disparities - Notice of Information: Change in Letter of Intent Due Dates for PAR-18-745 "Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional)"
National Institute on Minority Health and Health Disparities
National Institute on Drug Abuse - Notice Regarding New Applications for PAR-15-352: Occupational Safety and Health Training Project Grants (T03)
National Institute for Occupational Safety and Health
Requests for Applications
- Research Innovations for Scientific Knowledge (RISK) for Musculoskeletal Diseases (R61/R33 Clinical Trial Not Allowed)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required)
- Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
- BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)
- BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed)
- BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
- Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
Office of Strategic Coordination (Common Fund)
Program Announcements
- Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Minority Health and Health Disparities - Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
- Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed)
- Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R03 - Clinical Trial Optional)
- Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R21 - Clinical Trial Optional)
- Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01 - Clinical Trial Optional)
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
- Immune Response to Arthropod Blood Feeding (R21 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed)
National Eye Institute
- Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Details, including application deadlines, when applicable, are available through the program links above. To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Linda Meyer at linda-k-meyer@uiowa.edu, Paul Below at paul-below@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu